This report represents a solid research and benchmarking tool for market planners in diagnostics and laboratory test services for clinical purposes. Global Clinical Laboratory Service Market Analysis, Revenues by Region, 2016 (Northern America; Europe, Middle East, Africa; Asia Pacific; Latin America; Total)
- Northern America Market Value by Country, 2016 (Canada, United States, Rest of Northern America)
- U.S. Clinical Laboratory Market Analysis, 2010-2021
- U.S. Clinical Laboratory Market Analysis by Laboratory Type, 2010-2021 (Hospital-based, Physician-office, Independent, Total)
- Clinical Laboratory Market Share by Laboratory Type, 2021 (Independent, Hospital-based, Physician-office)
- U.S. Clinical Laboratory Market Analysis: Testing Service Revenues by Type, 2016 (Routine Clinical Chemistry, Toxicology / Drug abuse, Tissue Pathology, Other Specialty)
- Europe/Middle East and Africa Market Value by Country, 2016 (Germany, France, Italy, Spain, United Kingdom, Switzerland, Rest of EMEA, Total)
- Asia Pacific Market Value by Country, 2016 (China, Japan, India, South Korea, Australia, Rest of Asia Pacific, Total)
- Latin America Market Value by Country, 2016 (Brazil, Mexico, Rest of Latin America, Total)
- CHAPTER ONE: EXECUTIVE SUMMARY
- INDUSTRY AT A GLANCE
- SCOPE AND METHODOLOGY
- GLOBAL MARKET OVERVIEW
- Table 1-1: Global Clinical Laboratory Market Analysis, 2010-2021 (in millions of dollars at the manufacturer’s level)
- Figure 1-1: Global Clinical Laboratory Market Analysis: 2010-2021
- MARKET CONCLUSIONS
- KEY ISSUES AND TRENDS AFFECTING THE MARKET
- LEADING MARKET PARTICIPANTS
- CHAPTER TWO: INDUSTRY OVERVIEW
- CLINICAL LABORATORY DESCRIPTION
- TESTING AND SERVICES
- Routine Testing
- Table 2-1: Laboratory Reference Parameters for Complete Blood Count (CBC)
- Table 2-2: High Cholesterol Risk Categories (Desirable levels, Borderline high, High risk)
- Table 2-3: Raised or At-Risk Total Cholesterol (> = 190 mg/dL), Age Standardized Estimates, 2008 data (Iceland, Germany, Denmark,
- United Kingdom, Ireland, Italy, France, Netherlands, Switzerland, United Arab Emirates, Singapore, Japan, Poland, Thailand, Australia,
- United States, Israel, Canada, Mexico, Russian Federation, Argentina, Brazil, Philippines, Republic of Korea, Turkey, Saudi Arabia,
- Venezuela, China, India)
- Table 2-4: Number of Reported HIV Testing and Counseling Services by Country, 2014 (India, Ethiopia, Uganda, Kenya, Nigeria,
- Mozambique, South Africa, Rwanda, United Republic of Tanzania, Zambia, Mexico, Kazakhstan, Malawi, Viet Nam, Côte d'Ivoire,
- Democratic Republic of the Congo, Zimbabwe, Malaysia, Thailand, Haiti, Peru, Belarus, Indonesia, Burundi, Cuba)
- Table 2-5: Primary and Secondary Prevention of Cervical Cancer, Screening Responses by Country, 2015 (Afghanistan, Argentina,
- Australia, Belgium, Brazil, Canada, China, Democratic People's Republic of Korea, Denmark, France, Germany, India, Indonesia, Iran
- [Islamic Republic of], Iraq, Israel, Italy, Japan, Mexico, Netherlands, New Zealand, Philippines, Poland, Republic of Korea, Russian
- Federation, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Thailand, Turkey, United Arab Emirates, United Kingdom
- of Great Britain and Northern Ireland, United States of America, Venezuela [Bolivarian Republic of], Viet Nam)
- Table 2-6: HCG Levels in Pregnant Women by Days Past Ovulation
- Table 2-7: Substance Detection Periods by Test Method (Alcohol, Cocaine, Morphine, Phenobarbital, Methadone, PCP, LSD, Heroin,
- Methamphetamine; Urine, Blood, Hair)
- Table 2-8: Screening and Brief Interventions for Substance Abuse by Select Country, 2008 Data (Afghanistan, Australia, Austria,
- Belgium, Canada, China, Denmark, France, Germany, Greece, Hungary, Iceland, India, Indonesia, Iran [Islamic Republic of], Iraq,
- Ireland, Israel, Italy, Japan, Mexico, Netherlands, New Zealand, Norway, Pakistan, Philippines, Poland, Republic of Korea, Russian
- Federation, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Thailand, Turkey, Venezuela [Bolivarian Republic of])
- Table 2-9: Normal Reference Levels in a Medical Urinalysis
- Specialty Testing
- GLOBAL CLINICAL LABORATORY STRUCTURE
- Global Hospital/Acute Care Data
- Table 2-10: Hospital Density per 100,000 Population by Country, 2013 (Afghanistan, Brazil, Canada, China, France, Finland, Germany,
- Iceland, Indonesia, Iraq, Israel, Italy, Japan, Korea [Republic of], Malaysia, Mexico, Netherlands, Pakistan, Philippines, Poland, Saudi
- Arabia, Singapore, South Africa, Thailand, Turkey, United Kingdom, United States)
- Figure 2-1: Hospitals per 100,000 Population by Country, 2013 (Afghanistan, Brazil, Canada, China, France, Finland, Germany, Iceland,
- Indonesia, Iraq, Israel, Italy, Japan, Korea [Republic of], Malaysia, Mexico, Netherlands, Pakistan, Philippines, Poland, Saudi Arabia,
- Singapore, South Africa, Thailand, Turkey, United Kingdom, United States)
- Global Access to Physicians
- Table 2-11: Medical Doctors per 1,000 Population by Country, 2013 (Afghanistan, Argentina, Australia, Brazil, Canada, China, France,
- Germany, India, Ireland, Israel, Italy, Japan, Mexico, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Turkey, United
- Kingdom, United States, Vietnam)
- Figure 2-2: Medical Doctors per 1,000 Population by Country, 2013 (Afghanistan, Argentina, Australia, Brazil, Canada, China, France,
- Germany, India, Ireland, Israel, Italy, Japan, Mexico, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Turkey, United
- Kingdom, United States, Vietnam)
- CLIA Laboratory Registration, Laboratories by Type
- Figure 2-6: U.S. CLIA Clinical Laboratory Registration by Primary Laboratory Type: 1/2017 (Physician Office, Skilled Nursing / Nursing
- Facility, Home Health Agency, Hospital, Pharmacy, Community Clinic, ESRD Clinic, Independent, Others)
- Table 2-13: CLIA Registered Laboratories by Type of Facility (Exempt/Non-Exempt Combined), January 2017 (Ambulance, Ambulatory
- Surgery Center, Ancillary Test Site, Assisted Living Facility, Blood Bank, Community Clinic, Comprehensive Outpatient Rehab, End Stage
- Renal Disease Dialysis, Federally Qualified Health Center, Health Fair, Health Maintenance Organization, Home Health Agency, Hospice,
- Hospital, Independent, Industrial, Insurance, Intermediate Care Facility for Mentally Retarded, Mobile Laboratory, Pharmacy, Physician
- Office, Other Practitioner, Prison, Public Health Laboratory, Rural Health Clinic, School/Student Health Service, Skilled Nursing/Nursing
- Facility, Tissue Bank/Repository, Other, Total)
- Figure 2-7: Change in CLIA Registered Laboratories by Type of Facility (Exempt/Non-Exempt Combined) June 2013, July 2015 and
- January 2017 (Ambulance, Ambulatory Surgery Center, Ancillary Test Site, Assisted Living Facility, Blood Banks, Community Clinic,
- Comprehensive Outpatient Rehab, End Stage Renal Disease Dialysis, Federally Qualified Health Center, Health Fair, Health Maintenance
- Organization, Home Health Agency, Hospice, Hospital, Independent, Industrial, Insurance, Intermediate Care - Mentally Retarded, Mobile
- Laboratory, Pharmacy, Physician Office, Other Practitioner, Prison, Public Health Laboratory, Rural Health Clinic, School/Student Health
- Service, Skilled Nursing, Tissue Bank/Repositories, Other)
- Independent Clinical Laboratories
- Table 2-14: Leading U.S. Independent Laboratory Groups, as of January 2017
- Figure 2-8: Leading U.S. Independent Laboratory Groups, Distribution of Centers, as of January 2017
- Figure 2-9: Growth in U.S. Independent Laboratory Facilities, mid-2011 through January 2017
- Laboratory Health Workers by Country, 2010-2014 Average (United States, China, Brazil, Korea, Mexico, Canada)
- CHAPTER THREE: ISSUES AND TRENDS IN THE CLINICAL LABORATORY INDUSTRY
- ISSUES AND TRENDS OVERVIEW
- DEMOGRAPHICS
- Global Demographics
- Table 3-1: The Global Population, 1980-2050
- Figure 3-1: The Global Population, 1980-2050 (in millions)
- Regional Population Overview
- Table 3-2: World Population by Major Geographic Region, 2010 - 2050 (Asia Pacific, Europe, Northern America, Latin America, Rest of
- World, World)
- Figure 3-2: World Population by Major Geographic Region, 2010–2050 (Asia Pacific, Europe, Northern America, Latin America, Rest of
- World)
- Aging Populations
- Table 3-3: Global Population Trends Age 65+, 2000-2050
- Figure 3-3: Global Population Trends Age 65+, 2000-2050 (Millions)
- INCIDENCE OF CHRONIC DISEASES AND CONDITIONS
- Figure 3-4: Global Causes of Death, 2014 and 2015
- SURGICAL PROCEDURE VOLUMES
- Table 3-4: Global Surgical Procedure Volume Forecast by Region, 2015-2030*
- (procedures in thousands) (Northern America, Europe, Asia Pacific, Latin America, Rest of World, Total) .. 69
- REGULATORY OVERVIEW
- Certificate of Waiver
- Table 3-5: Selected CLIA Waived Laboratory Tests
- Certificate of Provider-Performed Microscopy Procedures (PPMP)
- Table 3-6: Provider-Performed Microscopy Procedures
- Certificate of Compliance and Certificate of Accreditation
- Figure 3-5: Clinical Laboratory Certificate of Accreditation Issued by Organization (non-exempt laboratories only), January 2017
- Table 3-7: Clinical Laboratory Certificates Issued by Type (non-exempt laboratories only), January 2017
- States Exempt from Federal Clinical Laboratory Improvements Amendments (CLIA) of 1988
- Table 3-8: CLIA Exempt States, Number of Laboratories, January 2017 (New York, Washington)
- PAYERS AND REIMBURSEMENT
- Laboratory Service Payer Types
- Table 3-9: U.S. Clinical Laboratory Clients and Payers by Type (%) (Medicare and Medicaid, Private Patient, Commercial Insurance,
- Managed Care)
- Figure 3-6: Clinical Laboratory Clients and Payers by Type (Medicare/Medicaid, Private, Commercial, Managed Care)
- Trends in Medicare Reimbursement
- Table 3-10: Medicare Reimbursement Trends, 2009 vs. 2013 vs. 2015 vs. 2016
- Health Care Reform
- Protecting Access to Medicare Act (PAMA) of 2014
- Bundled Insurance Payments for ESRD Patients
- Table 3-11: Laboratory Tests Subject to ESRD Consolidated Billing (CY 2017)
- Table 3-12: Comparison between New Bundled and Composite Medicare Reimbursement Program (1983-2010 and 2011+)
- Commercial Insurance Providers
- NEW DEVELOPMENTS IN INFORMATION TECHNOLOGY
- CHAPTER FOUR: LEADING MARKET PARTICIPANTS
- SUMMARY
- Figure 4-1: Leading Market Participants, Global Service Revenues, 2014, 2015 and 2016 ($millions)
- U.S. COMPETITIVE ANALYSIS
- Table 4-1: Estimated U.S. Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers, 2016
- Figure 4-2: Estimated U.S. Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers, 2016
- Figure 4-3: Estimated U.S. Laboratory Service Revenues for Leading Clinical Laboratory Providers, 2010 vs. 2016
- ALERE, INC.
- Company Overview
- Table 4-2: Alere Corporate Details
- Performance Review
- Figure 4-4: Alere Revenue Summary, 2010-2016 ($millions)
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- BIO-REFERENCE LABORATORIES - OPKO
- Company Overview
- Table 4-3: Bio-Reference Laboratories Corporate Details
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- DAVITA HEALTHCARE PARTNERS, INC.
- Company Overview
- Table 4-4: DaVita Healthcare Corporate Details
- Performance Review
- Figure 4-5: DaVita Revenue Summary, 2010-2016 ($millions)
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- GENOMIC HEALTH, INC.
- Company Overview
- Table 4-5: Genomic Health Corporate Details
- Performance Review
- Figure 4-6: Genomic Health Revenue Summary, 2010-2016 ($millions)
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- LABORATORY CORPORATION OF AMERICA
- Company Overview
- Table 4-6: Laboratory Corporation of America Corporate Details
- Performance Review
- Figure 4-7: Laboratory Corporation of America Revenue Summary, 2010-2016 ($millions)
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- MYRIAD GENETICS, INC.
- Company Overview
- Table 4-7: Myriad Genetics Corporate Details
- Performance Review
- Figure 4-8: Myriad Genetics Revenue Summary, 2010-2016 ($millions)
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- NEOGENOMICS, INC.
- Company Overview
- Table 4-8: NeoGenomics, Inc. Corporate Details
- Performance Review
- Figure 4-9: NeoGenomics Revenue Summary, 2010-2016 ($millions)
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- QUEST DIAGNOSTICS, INC.
- Company Overview
- Table 4-9: Quest Diagnostics Corporate Details
- Performance Review
- Figure 4-10: Quest Diagnostics Revenue Summary, 2010-2016 ($millions)
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- SIEMENS HEALTHINEERS
- Company Overview
- Table 4-10: Siemens Healthineers Corporate Details
- Performance Review
- Figure 4-11: Siemens' Healthineers Revenue Summary, 2010-2016 ($millions)
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- SONIC HEALTHCARE LIMITED
- Company Overview
- Table 4-11: Sonic Healthcare Corporate Details
- Performance Review
- Figure 4-12: Sonic Healthcare Revenue Summary, 2010-2016 ($millions)
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- SPECTRA LABORATORIES: A FRESENIUS COMPANY
- Company Overview
- Table 4-12: Spectra Laboratories Corporate Details
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- SYNLAB INTERNATIONAL GMBH
- Company Overview
- Table 4-13: SYNLAB International Corporate Details
- Performance Review
- Table 4-14: SYNLAB International Business Combination Details
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- CHAPTER FIVE: MARKET TRENDS AND SUMMARY
- GLOBAL MARKET OVERVIEW
- Table 5-1: Global Clinical Laboratory Market Analysis, 2010-2021 (in millions of dollars at the manufacturer’s level)
- Figure 5-1: Global Clinical Laboratory Market Analysis: 2010-2021
- SERVICE MARKETS BY TEST SEGMENT
- Figure 5-2: Global Clinical Laboratory Revenue Share by General Test Segment, 2016 (%)
- Table 5-2: Global Clinical Laboratory Market Analysis by Test Segment (Routine vs. Specialty), 2010-2021 (in millions of dollars at the
- manufacturers’ level)
- Routine Testing
- Table 5-3: Most Common Performed Routine Tests by Order Request, 2016
- Figure 5-3: Global Clinical Laboratory Market Analysis: Routine Testing Market Trend, 2010-2021
- Specialty Testing
- Table 5-4: Most Common Performed Specialty Tests by Order Request, 2016
- Figure 5-4: Global Clinical Laboratory Market Analysis: Specialty Testing Market Trend, 2010-2021
- CHAPTER SIX: REGIONAL MARKETS AND TRENDS
- OVERVIEW
- Table 6-1: Global Clinical Laboratory Service Market Analysis, Revenues by Region, 2016 (Northern America; Europe, Middle East,
- Africa; Asia Pacific; Latin America; Total)
- Figure 6-1: Global Clinical Laboratory Market Analysis, Revenues by Region, 2016 (Northern America; Europe, Middle East, Africa; Asia
- Pacific; Latin America)
- NORTHERN AMERICAN MARKET OVERVIEW
- Table 6-2: Northern America Market Value by Country, 2016 (in millions of dollars at the manufacturers’ level) (Canada, United States,
- Rest of Northern America)
- U.S. Clinical Laboratory Market
- Table 6-3: U.S. Clinical Laboratory Market Analysis, 2010-2021 (in millions of dollars at the manufacturer’s level)
- Figure 6-2: U.S. Clinical Laboratory Market Analysis: 2010-2021
- Market Analysis by Laboratory Type
- Table 6-4: U.S. Clinical Laboratory Market Analysis by Laboratory Type, 2010-2021 (in millions of dollars at the manufacturers’ level)
- (Hospital-based, Physician-office, Independent, Total)
- EUROPE AND MIDDLE EAST MARKET OVERVIEW
- Table 6-5: Europe/Middle East and Africa Market Value by Country, 2016 (in millions of dollars at the manufacturers’ level) (Germany,
- France, Italy, Spain, United Kingdom, Switzerland, Rest of EMEA, Total)
- ASIA PACIFIC MARKET OVERVIEW
- Table 6-6: Asia Pacific Market Value by Country, 2016 (in millions of dollars at the manufacturers’ level) (China, Japan, India, South
- Korea, Australia, Rest of Asia Pacific, Total)
- LATIN AMERICA MARKET OVERVIEW
- Table 6-7: Latin America Market Value by Country, 2016 (in millions of dollars at the manufacturers’ level) (Brazil, Mexico, Rest of Latin
- America, Total)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook